Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.51
+0.08 (0.39%)
At close: Feb 24, 2026, 4:00 PM EST
20.22
-0.29 (-1.43%)
After-hours: Feb 24, 2026, 4:33 PM EST

Sabra Health Care REIT Statistics

Total Valuation

SBRA has a market cap or net worth of $5.17 billion. The enterprise value is $7.63 billion.

Market Cap5.17B
Enterprise Value 7.63B

Important Dates

The last earnings date was Thursday, February 12, 2026, after market close.

Earnings Date Feb 12, 2026
Ex-Dividend Date Feb 13, 2026

Share Statistics

SBRA has 252.15 million shares outstanding. The number of shares has increased by 3.58% in one year.

Current Share Class 252.15M
Shares Outstanding 252.15M
Shares Change (YoY) +3.58%
Shares Change (QoQ) +3.78%
Owned by Insiders (%) 1.70%
Owned by Institutions (%) 101.89%
Float 247.78M

Valuation Ratios

The trailing PE ratio is 32.05 and the forward PE ratio is 29.65. SBRA's PEG ratio is 3.55.

Price/FFO Ratio 13.86
Price/AFFO Ratio n/a
PE Ratio 32.05
Forward PE 29.65
PS Ratio 6.67
Forward PS 6.58
PB Ratio 1.82
P/TBV Ratio 1.88
P/FCF Ratio n/a
P/OCF Ratio 14.83
PEG Ratio 3.55
Financial Ratio History

Enterprise Valuation

EV / Earnings 49.06
EV / Sales 9.84
EV / EBITDA 17.07
EV / EBIT 28.81
EV / FCF n/a

Financial Position

The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.90.

Current Ratio 1.81
Quick Ratio 1.47
Debt / Equity 0.90
Debt / EBITDA 5.66
Debt / FCF n/a
Interest Coverage 2.78

Financial Efficiency

Return on equity (ROE) is 5.59% and return on invested capital (ROIC) is 4.86%.

Return on Equity (ROE) 5.59%
Return on Assets (ROA) 3.07%
Return on Invested Capital (ROIC) 4.86%
Return on Capital Employed (ROCE) 4.93%
Weighted Average Cost of Capital (WACC) 6.47%
Revenue Per Employee $13.38M
Profits Per Employee $2.68M
Employee Count58
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

In the past 12 months, SBRA has paid $1.84 million in taxes.

Income Tax 1.84M
Effective Tax Rate 1.17%

Stock Price Statistics

The stock price has increased by +29.08% in the last 52 weeks. The beta is 0.65, so SBRA's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change +29.08%
50-Day Moving Average 19.18
200-Day Moving Average 18.61
Relative Strength Index (RSI) 65.77
Average Volume (20 Days) 3,074,813

Short Selling Information

The latest short interest is 22.17 million, so 8.79% of the outstanding shares have been sold short.

Short Interest 22.17M
Short Previous Month 22.77M
Short % of Shares Out 8.79%
Short % of Float 8.95%
Short Ratio (days to cover) 8.79

Income Statement

In the last 12 months, SBRA had revenue of $775.76 million and earned $155.61 million in profits. Earnings per share was $0.64.

Revenue775.76M
Gross Profit 505.70M
Operating Income 265.00M
Pretax Income 157.35M
Net Income 155.61M
EBITDA 447.11M
EBIT 265.00M
Earnings Per Share (EPS) $0.64
Full Income Statement

Balance Sheet

The company has $74.92 million in cash and $2.54 billion in debt, with a net cash position of -$2.46 billion or -$9.77 per share.

Cash & Cash Equivalents 74.92M
Total Debt 2.54B
Net Cash -2.46B
Net Cash Per Share -$9.77
Equity (Book Value) 2.82B
Book Value Per Share 11.21
Working Capital 96.39M
Full Balance Sheet

Cash Flow

Operating Cash Flow 348.61M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 65.19%, with operating and profit margins of 34.16% and 20.06%.

Gross Margin 65.19%
Operating Margin 34.16%
Pretax Margin 20.28%
Profit Margin 20.06%
EBITDA Margin 57.64%
EBIT Margin 34.16%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 5.85%.

Dividend Per Share $1.20
Dividend Yield 5.85%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 187.50%
Buyback Yield -3.58%
Shareholder Yield 2.27%
Earnings Yield 3.01%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SBRA is $21.44, which is 4.53% higher than the current price. The consensus rating is "Buy".

Price Target $21.44
Price Target Difference 4.53%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 11.03%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5